Older adults who volunteered more often had better emotional well-being, were less likely to have Alzheimer’s disease and had lower risks for not being able to perform activities of daily living.
Vigorous exercise may guard against death from Alzheimer’s disease
By
Kristen Fischer
Dec 18, 2023
Engaging in vigorous activity compared to moderate exercise may lower the rate of dying from Alzheimer’s disease, according to a new study. The study was published in the December issue of The Lancet...
Clinical briefs for Thursday, Nov. 16
By
Kristen Fischer
Nov 16, 2023
Study links military service with Alzheimer’s disease … Drug could “switch” memory protein in brain …Gene therapy for osteoarthritis looks good in trial … Nurses still need better support,...
Scent waning? This Alzheimer’s gene may be the culprit, study shows
By
Kristen Fischer
Jul 27, 2023
Sense of smell may be the first to go in people who carry a gene variant that’s linked to the highest risk for Alzheimer’s disease, according to a new study.
Medicare costs could rise by $5B annually with expanded Alzheimer’s drug coverage: study
By
Alicia Lasek
May 12, 2023
Medicare costs could rise by $2 to $5 billion a year if CMS expands its coverage for newly approved Alzheimer’s disease drug Leqembi (lecanemab), investigators say.
Survey: U.S. neurologists would prescribe Leqembi if fully approved
By
Alicia Lasek
Apr 12, 2023
A “healthy proportion” of surveyed neurologists have already begun prescribing the treatment, and nearly all said they planned to do so if traditional FDA approval is granted.
Hurricanes hastened the deaths of adults with dementia, study finds
By
Alicia Lasek
Mar 08, 2023
People with Alzheimer’s and related dementias (ADRD) had higher mortality rates in U.S. counties that had recently experienced a hurricane disaster, investigators report.
Vitamin D may protect against Alzheimer’s, new report asserts
By
Alicia Lasek
Mar 06, 2023
Exposure to vitamin D supplements is linked to longer dementia-free survival and a lower rate of dementia when compared to no exposure, a new study has found.
Battle over Alzheimer’s drug coverage is hardly a no-brainer
By
John O'Connor
Feb 26, 2023
Well, it looks like we have a good old fashioned war of words developing over Alzheimer’s drug coverage. It’s a battle well worth watching.